SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharma signs agreement with RPG life science to divest 7 prescription brands

27 Jul 2016 Evaluate

Sun Pharmaceutical has signed an agreement with RPG life science to divest seven prescription brands in India, owned by Sun Pharmaceutical Industries and its subsidiary, for a consideration of Rs 41 crore. This divestment is subject to receipt of Competition Commission of India’s (CCI) approval.

The seven divested brands include brands used for treatment of respiratory-track infections, urological disorders, cardiovascular diseases and brands in health supplements segment.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices.

Sun Pharma Inds. Share Price

1873.25 25.95 (1.40%)
11-May-2026 13:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1873.25
Dr. Reddys Lab 1294.10
Cipla 1321.45
Zydus Lifesciences 948.00
Lupin 2277.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×